Edmundo BRITO DE LA FUENTE,Ericka PESTANA,Sarah ASHLEY-MAGUIRE,José Maria MAINOU-SIERRA,Maria Fernanda MARTINEZ-BOCK,Stephanie REICHART
申请号：
US16349857
公开号：
US20190374495A1
申请日:
2017.11.16
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention relates to PUFA, vitamin E, vitamin D and the protein bound amino acids glycine, arginine and tryptophan as active ingredients for use in therapy of cancer patients, wherein an effective amount of said active ingredients is administered in the form of a nutritional composition comprising a) a lipid component providing 40-50 EN % based on the total energy of the nutritional composition, wherein 12-16 EN % based on the total energy of the nutritional composition is provided by PUFA, b) 4.0-8.0 mg/100 mL alpha-TE vitamin E, c) 5.0-12.0 μg/100 mL vitamin D, d) 2.5-4.5 g/100 mL glycine, e) 0.5-1.5 g/100 mL arginine, and f) at least 0.02 g/100 mL tryptophan.
